Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Analytical Chemistry

Raman imaging identifies which bacteria are susceptible to antibiotics

Method can distinguish sensitive and resistant bacteria within 30 minutes

by Celia Henry Arnaud
March 19, 2018 | A version of this story appeared in Volume 96, Issue 12

Many bacteria are resistant to antibiotics, so the sooner an infection’s antibiotic susceptibility can be determined, the sooner an effective treatment can be devised. But current clinical methods for determining antibiotic susceptibility involve bacterial culture and can take more than a day. To accelerate the process, Mohamed N. Seleem of Purdue University, Ji-Xin Cheng of Boston University, and coworkers used stimulated Raman scattering (SRS) microscopy of carbon-deuterium bonds to monitor glucose metabolism of Enterococcus faecalis at the single-bacterium level (Anal. Chem. 2018, DOI: 10.1021/acs.analchem.7b03382). By using so-called hyperspectral SRS, they can acquire a complete spectrum at each pixel. The Raman spectrum changes in response to the metabolic activity of the bacteria. When the researchers treated susceptible and resistant E. faecalis with vancomycin and fed the bacteria deuterated glucose, differences in the bugs’ incorporation of glucose in proteins and lipids were apparent within a half hour of treatment. That’s fast enough to determine antibiotic susceptibility within a single bacterial cell cycle. The researchers also showed that the method is applicable to other types of bacteria and antibiotics.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.